Online Resources for Prostate Cancer

More information about treatments, research, rehabilitation,
and support

There is a lot to know about prostate cancer. The following websites provide information about prostate cancer, advanced prostate cancer research, treatment options, education, rehabilitation, advocacy groups, and local prostate cancer support groups.

The websites and information resources listed are not the property of AbbVie Inc. AbbVie Inc. does not assure the accuracy or timeliness of the information, and provides these references for your convenience only.

American Urological
Association Foundation

www.urologyhealth.org
1.800.828.7866

The AUA Foundation is the world's leading nonprofit urological health foundation—and the official foundation of the American Urological Association. They partner with physicians, researchers, healthcare professionals, patients, caregivers, families, and the public to support and improve the prevention, detection, and treatment of urological diseases.

Men’s Health Network
www.menshealthnetwork.org
202.543.6461 ext. 101

Men's Health Network (MHN) is a national nonprofit organization whose mission is to reach men and their families where they live, work, play, and pray with health prevention messages and tools, screening programs, educational materials, advocacy opportunities, and patient navigation.

National Cancer Institute
www.cancer.gov
1.800.422.6237

This useful gateway into the National Cancer Institute allows users to access a portion of the contents of PDQ—the Physician Data Query database. With detailed information about specific cancers, PDQ is written for both medical professionals and patients.

National Coalition for
Cancer Survivorship

www.canceradvocacy.org
301.650.9127 or 1.877.622.7937

This is a grassroots network of individuals and organizations working on behalf of people with all types of cancer.

National Comprehensive
Cancer Network

www.nccn.com
215.690.0300

NCCN is dedicated to improving the quality and effectiveness of cancer care. This not-for-profit organization is made up of 21 of the world’s leading cancer centers. The network develops treatment guidelines, including the NCCN National Comprehensive Cancer Network® (NCCN) Guidelines for Patients: Prostate Cancer, which you can find on the site.

Patient Advocates for Advanced
Cancer Treatments (PAACT)

www.paactusa.org
616.453.1477

The PAACT organization’s very capable staff members share a common desire to help patients become aware of what is known about prostate cancer. PAACT helps patients to participate in their own health improvement and can direct them to appropriate physicians and medical centers of excellence for treatment.

Prostate Cancer Facts
www.prostatecancerfacts.com

Prostate Cancer Facts is a website from AbbVie that explains the basic facts about prostate cancer risks, symptoms, testing, and treatment. It also lists resources for patients, and keeps you up-to-date with events that promote prostate cancer awareness and raise funds for research.

Prostate Cancer Foundation
www.prostatecancerfoundation.org
1.800.757.2873

Prostate Cancer Foundation (PCF), an organization dedicated to finding a cure for prostate cancer, is the largest private source for research funding for prostate cancer. It offers information on prostate cancer, treatment options, and clinical trials, and personal stories of survival.

Prostate Cancer
Research Institute (PCRI)

www.prostate-cancer.org
1.800.641.7274

PCRI is a charitable not-for-profit organization whose mission is to improve the quality of men’s lives by supporting research and disseminating information that educates and empowers patients, families, and the medical community.

Prostate Conditions
Education Council (PCEC)

www.prostateconditions.org
1.866.477.6788

A national organization committed to men’s health, PCEC is the nation’s leading resource for information on prostate health.

The Prostate Health
Education Network (PHEN)

www.prostatehealthed.org
781.487.2239

PHEN's primary mission is to increase prostate health education and awareness. PHEN's working philosophy is that “knowledge is the best defense against prostate cancer.” The organization focuses on men at the highest risk for prostate cancer in the United States.

Us TOO International Prostate Cancer
Education and Support Network

www.ustoo.org
630.795.1002

Helps survivors of prostate cancer and prostate disease and their families foster a positive mental outlook. This organization offers fellowship, shared counseling, and discussion sessions in both formal and informal settings.

  • Do Not Take If
    • You should not take LUPRON DEPOT if you have had any type of allergic reaction to LUPRON DEPOT or similar drugs.
    • Females who are or may become pregnant should not receive any formulation of LUPRON DEPOT.

    Reference:
    LUPRON DEPOT 7.5 mg for
    1-month, 22.5 mg for 3-month,
    30 mg for 4-month, and 45 mg for 6-month [package insert].

  • Before Starting
    • Talk to your doctor about your medical history and all other medicines that you take.
    • Increased risk of heart attack, sudden death, and stroke can occur in men using LUPRON DEPOT. Discuss this increased risk with your doctor before starting treatment and report any new symptoms during treatment.
    • LUPRON DEPOT can affect the electrical activity of your heart. Your doctor must determine if the benefits of using LUPRON DEPOT outweigh the risks, especially if you have congenital long QT syndrome, abnormal blood tests for electrolytes, congestive heart failure, or if you take medications to regulate your heartbeat.
    • Convulsions have been observed in patients taking leuprolide acetate, including patients who have a history of seizures, epilepsy, or brain disorders (related to blood vessels, nerves, or tumors), and in those taking medications associated with convulsions. Convulsions have also been reported in patients without any of these conditions.

    Reference:
    LUPRON DEPOT 7.5 mg for
    1-month, 22.5 mg for 3-month,
    30 mg for 4-month, and 45 mg for 6-month [package insert].

  • What to Expect
    • LUPRON DEPOT causes an increase in testosterone during the first few weeks of therapy.
      • Some men may experience temporary new or worsening symptoms of prostate cancer, including urinary symptoms and/or bone pain.
      • If your cancer has spread to the spine or urinary tract, urinary blockage or pressure on the spine may occur and can sometimes lead to paralysis, which may be life-threatening.
      • You may require close medical attention during the first few weeks of therapy. Notify your doctor if you develop any new or worsened symptoms after beginning LUPRON DEPOT treatment.
    • High blood sugar and increased risk of diabetes can occur in men using LUPRON DEPOT. Your doctor will monitor your blood sugar during treatment.
    • Regular blood tests are needed to check your testosterone and prostate-specific antigen (PSA) levels.
    • LUPRON DEPOT may cause impotence.

    Reference:
    LUPRON DEPOT 7.5 mg for
    1-month, 22.5 mg for 3-month,
    30 mg for 4-month, and 45 mg for 6-month [package insert].

  • Side Effects
    • The most common side effects of LUPRON DEPOT include hot flashes/sweats; injection site reactions/pain; general pain; swelling; testicular shrinkage; difficulty urinating; fatigue/weakness; headache; and joint, gastrointestinal, and respiratory problems.

    For more information, talk with your healthcare provider.

    Reference:
    LUPRON DEPOT 7.5 mg for
    1-month, 22.5 mg for 3-month,
    30 mg for 4-month, and 45 mg for 6-month [package insert].

  • Helpful Resources

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

    If you cannot afford your medication, contact www.pparx.org for assistance.

    View the full Prescribing Information for LUPRON DEPOT at www.rxabbvie.com/pdf/
    lupronuro_pi.pdf
    .

    Reference:
    LUPRON DEPOT 7.5 mg for
    1-month, 22.5 mg for 3-month,
    30 mg for 4-month, and 45 mg for 6-month [package insert].

Print
Safety Facts
  • LUPRON DEPOT 7.5 mg for 1-month, 22.5 mg for 3-month, 30 mg for 4-month, and 45 mg for 6-month administration are prescribed for the palliative treatment of advanced prostate cancer.
  • LUPRON DEPOT is a prescription medication that must be administered in your doctor’s office.
Reference:
LUPRON DEPOT 7.5 mg for 1-month, 22.5 mg for 3-month, 30 mg for 4-month, and 45 mg for 6-month [package insert].